Evidence map›Paper›PMID 39606129›Full record

ReviewCureus2024

Considerations for Physicians Treating Skin of Color: A Narrative Review.

Hana Elhassan

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Hana ElhassanDermatology, Lauriston Building, Edinburgh, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical research and medical education regarding dermatoses in people with skin of color (SoC) have historically been neglected, which has played a role in physicians lacking confidence and competence in recognizing and managing dermatoses in diverse cohorts. This has contributed to poorer outcomes in people with SoC in objective domains, such as disease severity indices and prognoses, and subjective domains, such as patient-reported quality-of-life indices. In the first instance, physicians should understand the basic physiological differences underpinning SoC diversity and its clinical implications. This narrative review provides an introductory evidence-based discussion on clinically important topics relating to SoC aimed at non-dermatologists. Topics covered include the cellular basis underpinning skin color diversity and how this affects photodermatoses and malignancies, as well as an overview of how scarring and inflammatory conditions may present differently in people with SoC.

Indexed as

healthcare outcomeshealth inequalitymedical dermatologymedical educationskin of color

Identifiers

PMID39606129
PMCPMC11600459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.